AP
Healthcare & Life Sciences
Alkeus Pharmaceuticals
United States
Alkeus Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Alkeus Pharmaceuticals
Alkeus Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Alkeus Pharmaceuticals is a clinical-stage, single asset company developing ALK-001 for the treatment of Stargardt’s disease. Founded in 2021 and headquartered in Cambridge, MA, it focuses on therapeutics for rare inherited retinal diseases.
Explore Alkeus Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.